Skip to main content
PMC home page
Gut logoLink to Gut
. 1987 Apr;28(4):482–487. doi: 10.1136/gut.28.4.482

Cytomegalovirus colitis and oesophageal ulceration in the context of AIDS: clinical manifestations and preliminary report of treatment with Foscarnet (phosphonoformate).

J N Weber, S Thom, I Barrison, R Unwin, S Forster, D J Jeffries, A Boylston, A J Pinching
PMCID: PMC1432827  PMID: 3034745

Abstract

Three patients with biopsy diagnosed invasive cytomegalovirus infection of the colon have been seen in the context of the acquired immune deficiency syndrome (AIDS). Cytomegalovirus colitis presented with fever, abdominal distention, bloody diarrhoea and weight loss. Plain abdominal radiographs showed generalised large bowel dilatation in one patient. Cytomegalovirus infection was shown histologically, but the virus could not be cultured from the stool; no other gastrointestinal pathogens could be demonstrated. The patients were treated with a 14 day continuous infusion of Foscarnet 0.08 mg/kg/min (phosphonoformate, Astra Pharmaceuticals). One patient showed a partial response to therapy, but the cytomegalovirus colitis relapsed; the second patient had a symptomatic response only and the third patient died of non-cytomegalovirus opportunist infection while on treatment. Two other patients with biopsy proven cytomegalovirus ulceration of the oesophagus were seen, presenting with dysphagia, fever and weight loss. Invasive infection of the gastrointestinal tract with cytomegalovirus is now a major clinical problem in AIDS. Treatment with Foscarnet may be initially effective, but does not eliminate cytomegalovirus infection.

Full text

PDF
487

Images in this article

483Fig. 1
on p.483
485Fig. 2
on p.485
486Fig. 3
on p.486

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bach M. C., Bagwell S. P., Knapp N. P., Davis K. M., Hedstrom P. S. 9-(1,3-Dihydroxy-2-propoxymethyl)guanine for cytomegalovirus infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med. 1985 Sep;103(3):381–382. doi: 10.7326/0003-4819-103-3-381. [DOI] [PubMed] [Google Scholar]
  2. Biggar R. J., Andersen H. K., Ebbesen P., Melbye M., Goedert J. J., Mann D. L., Strong D. M. Seminal fluid excretion of cytomegalovirus related to immunosuppression in homosexual men. Br Med J (Clin Res Ed) 1983 Jun 25;286(6383):2010–2012. doi: 10.1136/bmj.286.6383.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cooper H. S., Raffensperger E. C., Jonas L., Fitts W. T., Jr Cytomegalovirus inclusions in patients with ulcerative colitis and toxic dilation requiring colonic resection. Gastroenterology. 1977 Jun;72(6):1253–1256. [PubMed] [Google Scholar]
  4. Dolin R. Antiviral chemotherapy and chemoprophylaxis. Science. 1985 Mar 15;227(4692):1296–1303. doi: 10.1126/science.2983421. [DOI] [PubMed] [Google Scholar]
  5. Felsenstein D., D'Amico D. J., Hirsch M. S., Neumeyer D. A., Cederberg D. M., de Miranda P., Schooley R. T. Treatment of cytomegalovirus retinitis with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine. Ann Intern Med. 1985 Sep;103(3):377–380. doi: 10.7326/0003-4819-103-3-377. [DOI] [PubMed] [Google Scholar]
  6. Foucar E., Mukai K., Foucar K., Sutherland D. E., Van Buren C. T. Colon ulceration in lethal cytomegalovirus infection. Am J Clin Pathol. 1981 Dec;76(6):788–801. doi: 10.1093/ajcp/76.6.788. [DOI] [PubMed] [Google Scholar]
  7. Freeman W. R., Lerner C. W., Mines J. A., Lash R. S., Nadel A. J., Starr M. B., Tapper M. L. A prospective study of the ophthalmologic findings in the acquired immune deficiency syndrome. Am J Ophthalmol. 1984 Feb;97(2):133–142. doi: 10.1016/s0002-9394(14)76082-9. [DOI] [PubMed] [Google Scholar]
  8. Goodman Z. D., Boitnott J. K., Yardley J. H. Perforation of the colon associated with cytomegalovirus infection. Dig Dis Sci. 1979 May;24(5):376–380. doi: 10.1007/BF01297124. [DOI] [PubMed] [Google Scholar]
  9. Hawley D. A., Schaefer J. F., Schulz D. M., Muller J. Cytomegalovirus encephalitis in acquired immunodeficiency syndrome. Am J Clin Pathol. 1983 Dec;80(6):874–877. doi: 10.1093/ajcp/80.6.874. [DOI] [PubMed] [Google Scholar]
  10. Lange M., Klein E. B., Kornfield H., Cooper L. Z., Grieco M. H. Cytomegalovirus isolation from healthy homosexual men. JAMA. 1984 Oct 12;252(14):1908–1910. [PubMed] [Google Scholar]
  11. Macher A. M., Reichert C. M., Straus S. E., Longo D. L., Parrillo J., Lane H. C., Fauci A. S., Rook A. H., Manischewitz J. F., Quinnan G. V., Jr Death in the AIDS patient: role of cytomegalovirus. N Engl J Med. 1983 Dec 8;309(23):1454–1454. doi: 10.1056/NEJM198312083092312. [DOI] [PubMed] [Google Scholar]
  12. Masur H., Lane H. C., Palestine A., Smith P. D., Manischewitz J., Stevens G., Fujikawa L., Macher A. M., Nussenblatt R., Baird B. Effect of 9-(1,3-dihydroxy-2-propoxymethyl) guanine on serious cytomegalovirus disease in eight immunosuppressed homosexual men. Ann Intern Med. 1986 Jan;104(1):41–44. doi: 10.7326/0003-4819-104-1-41. [DOI] [PubMed] [Google Scholar]
  13. Meiselman M. S., Cello J. P., Margaretten W. Cytomegalovirus colitis. Report of the clinical, endoscopic, and pathologic findings in two patients with the acquired immune deficiency syndrome. Gastroenterology. 1985 Jan;88(1 Pt 1):171–175. doi: 10.1016/s0016-5085(85)80150-5. [DOI] [PubMed] [Google Scholar]
  14. Mindel A., Weller I. V., Faherty A., Sutherland S., Hindley D., Fiddian A. P., Adler M. W. Prophylactic oral acyclovir in recurrent genital herpes. Lancet. 1984 Jul 14;2(8394):57–59. doi: 10.1016/s0140-6736(84)90237-x. [DOI] [PubMed] [Google Scholar]
  15. Mintz L., Drew W. L., Miner R. C., Braff E. H. Cytomegalovirus infections in homosexual men. An epidemiological study. Ann Intern Med. 1983 Sep;99(3):326–329. doi: 10.7326/0003-4819-99-3-326. [DOI] [PubMed] [Google Scholar]
  16. Oberg B. Antiviral effects of phosphonoformate (PFA, foscarnet sodium). Pharmacol Ther. 1982;19(3):387–415. doi: 10.1016/0163-7258(82)90074-2. [DOI] [PubMed] [Google Scholar]
  17. Quinnan G. V., Jr, Masur H., Rook A. H., Armstrong G., Frederick W. R., Epstein J., Manischewitz J. F., Macher A. M., Jackson L., Ames J. Herpesvirus infections in the acquired immune deficiency syndrome. JAMA. 1984 Jul 6;252(1):72–77. [PubMed] [Google Scholar]
  18. Sandstrom E. G., Kaplan J. C., Byington R. E., Hirsch M. S. Inhibition of human T-cell lymphotropic virus type III in vitro by phosphonoformate. Lancet. 1985 Jun 29;1(8444):1480–1482. doi: 10.1016/s0140-6736(85)92255-x. [DOI] [PubMed] [Google Scholar]
  19. Sonnabend J., Witkin S. S., Purtilo D. T. Acquired immunodeficiency syndrome, opportunistic infections, and malignancies in male homosexuals. A hypothesis of etiologic factors in pathogenesis. JAMA. 1983 May 6;249(17):2370–2374. [PubMed] [Google Scholar]
  20. Stover D. E., White D. A., Romano P. A., Gellene R. A., Robeson W. A. Spectrum of pulmonary diseases associated with the acquired immune deficiency syndrome. Am J Med. 1985 Mar;78(3):429–437. doi: 10.1016/0002-9343(85)90334-1. [DOI] [PubMed] [Google Scholar]
  21. Straus S. E., Seidlin M., Takiff H., Jacobs D., Bowen D., Smith H. A. Oral acyclovir to suppress recurring herpes simplex virus infections in immunodeficient patients. Ann Intern Med. 1984 Apr;100(4):522–524. doi: 10.7326/0003-4819-100-4-522. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES